Pricing Log in Create free account

Kura Oncology, Inc. (KURA) vs Verastem, Inc. (VSTM)

Kura Oncology, Inc. and Verastem, Inc. are both Biotechnology companies. Kura Oncology, Inc. and Verastem, Inc. are of similar size ($862.9M and $835.9M). Verastem, Inc. has the higher net margin (−231.6% vs −384.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Kura Oncology, Inc. leads on 9 and Verastem, Inc. on 6.

Valuation

Metric KURA VSTM Biotechnology median
P/E n/m n/m 8.50
P/S 10.45 9.89 9.71
P/B 16.66 17.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.85 9.29 9.21
Earnings yield (37.11%) (28.44%) (33.15%)
Free cash flow yield (14.55%) (18.73%) (25.50%)

Profitability

Metric KURA VSTM Biotechnology median
Gross margin 99.35% 86.35% 65.16%
Operating margin (411.90%) (182.57%) 0.00%
Net margin (384.30%) (231.59%) 0.00%
Free cash flow margin (152.06%) (185.31%) 0.00%
Return on equity (167.71%) (471.16%) (56.36%)
Return on assets (46.73%) (100.65%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KURA VSTM Biotechnology median
Revenue growth (TTM) — 472.89% 6.02%
EPS growth (last fiscal year) (57.43%) 17.49% 30.26%
Revenue growth, 5-year CAGR — 12.11% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KURA VSTM Biotechnology median
Debt to equity 0.20 1.48 0.00
Current ratio 4.73 2.25 4.72
Net debt to EBITDA 2.11 0.76 0.96

Dividend

Metric KURA VSTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KURA VSTM Biotechnology median
Market cap 862.92m 835.90m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack